At the MENA Conference on Rare Diseases to be held in Abu Dhabi from May 16, 2024
19 April 2024
Safety and efficacy of our beta-glucan product, “neu REFIX®“, will be presented at the MENA Conference on Rare Diseases to be held in Abu Dhabi from May 16, 2024.
The MENA Rare Diseases Conference brings together experts from various medical fields for presentations, workshops, and group meetings on rare diseases, as well as the latest developments in the diagnosis and treatment of rare diseases and medical and support services for patients. We will be presenting evidence of “Neu-Refix” in Duchenne muscular dystrophy, both in mdx mice pre-clinically and clinically in patients with diagnosis of DMD, BMD and LGMD.
For more information on the conference, please click here.
https://menararediseases.com/
